Sesquient

Active Ingredient(s): Fosphenytoin Sodium
FDA Approved: * November 5, 2020
Pharm Company: * SEDOR PHARMS LLC
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sesquient Overview

Fosphenytoin, also known as fosphenytoin sodium, and sold under the brand name Cerebyx among others, is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is used in the acute treatment of convulsive status epilepticus. Fosphenytoin was developed in 1996.[1] On 18 November 2004, Sicor (a subsidiary of Teva) received a tentative approval letter from the United States Food and Drug Adm...

Read more Sesquient Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fosphenytoin

Recent Sesquient Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fosphenytoin Sodium
  • Injection: 50mg, 50mg/ml, 75mg/ml, eq 50mg phenytoin na/ml
  • Solution: Eq 100mg Phenytoin Na/2ml (eq 50mg Phenytoin Na/ml), Eq 500mg Phenytoin Na/10ml (eq 50mg Phenytoin Na/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Fosphenytoin Sodium or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA